ERBB2 and breast carcinoma: Furthermore, previous studies have demonstrated that BLBCs with HER2 expression, which can be termed as a basal–HER2+ subtype, are associated with a worse prognosis compared to basal-like or HER2+ subtype breast cancer [4,5].